ABS Investment Management LLC Invests $2.22 Million in Sotera Health Company $SHC

ABS Investment Management LLC purchased a new position in Sotera Health Company (NASDAQ:SHC - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 125,000 shares of the company's stock, valued at approximately $2,218,750. Sotera Health accounts for 0.0% of ABS Investment Management LLC's portfolio, making the stock its 16th biggest position.

Other large investors also recently modified their holdings of the company. CenterBook Partners LP raised its holdings in Sotera Health by 94.1% in the 4th quarter. CenterBook Partners LP now owns 151,529 shares of the company's stock valued at $2,673,000 after acquiring an additional 73,473 shares in the last quarter. Militia Capital Management LLC acquired a new position in shares of Sotera Health in the 1st quarter valued at $3,877,000. Geode Capital Management LLC raised its stake in shares of Sotera Health by 13.8% in the 4th quarter. Geode Capital Management LLC now owns 3,931,834 shares of the company's stock valued at $69,372,000 after buying an additional 476,365 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of Sotera Health by 13.4% in the 1st quarter. Bank of New York Mellon Corp now owns 1,403,971 shares of the company's stock valued at $20,133,000 after buying an additional 166,055 shares in the last quarter. Finally, Balefire LLC acquired a new position in shares of Sotera Health in the 1st quarter valued at $1,476,000. Institutional investors own 91.03% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on SHC shares. Citigroup increased their price objective on shares of Sotera Health from $23.00 to $25.00 and gave the company a "buy" rating in a research note on Friday, August 7th. Wall Street Zen upgraded shares of Sotera Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday. The Goldman Sachs Group started coverage on shares of Sotera Health in a research note on Friday, June 5th. They issued a "buy" rating and a $20.00 price objective for the company. JPMorgan Chase & Co. increased their target price on Sotera Health from $16.00 to $18.00 and gave the stock a "neutral" rating in a report on Friday, August 7th. Finally, Weiss Ratings raised Sotera Health from a "hold (c)" rating to a "hold (c+)" rating in a report on Tuesday, August 11th. Eight analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $21.50.

Insider Transactions at Sotera Health

In other Sotera Health news, Chairman Michael B. Jr. Petras sold 850,000 shares of the business's stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $18.50, for a total value of $15,725,000.00. Following the completion of the transaction, the chairman directly owned 3,969,393 shares of the company's stock, valued at approximately $73,433,770.50. The trade was a 17.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Michael P. Rutz sold 150,000 shares of the business's stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the transaction, the insider directly owned 334,279 shares of the company's stock, valued at approximately $6,297,816.36. This represents a 30.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 1,294,515 shares of company stock valued at $23,999,528. Insiders own 15.36% of the company's stock.

Sotera Health Trading Down 1.1%

SHC stock opened at $19.27 on Friday. The business has a fifty day moving average price of $18.12 and a 200 day moving average price of $16.41. Sotera Health Company has a fifty-two week low of $13.09 and a fifty-two week high of $19.85. The stock has a market capitalization of $5.50 billion, a price-to-earnings ratio of 33.81 and a beta of 1.77. The company has a debt-to-equity ratio of 3.33, a current ratio of 2.80 and a quick ratio of 2.55.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The firm had revenue of $321.38 million during the quarter, compared to analysts' expectations of $309.70 million. During the same period last year, the firm posted $0.20 EPS. The business's revenue was up 9.2% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Analysts expect that Sotera Health Company will post 0.86 EPS for the current fiscal year.

About Sotera Health

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.